Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v7-FR
Language English French
Date Updated 2024-04-24 2024-02-20
Drug Identification Number 02241837 02241837
Brand name ESTALIS 250/50 MCG ESTALIS 250/50 MCG
Common or Proper name ESTALIS 250/50 MCG ESTALIS 250/50 MCG
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients NORETHINDRONE ACETATE ESTRADIOL NORETHINDRONE ACETATE ESTRADIOL
Strength(s) 250MCG 50MCG 250MCG 50MCG
Dosage form(s) PATCH PATCH
Route of administration TRANSDERMAL TRANSDERMAL TRANSDERMAL TRANSDERMAL
Packaging size 8TTSM 8TTSM
ATC code G03FA G03FA
ATC description PROGESTOGENS AND ESTROGENS IN COMBINATION PROGESTOGENS AND ESTROGENS IN COMBINATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-01-16 2024-01-16
Estimated end date 2024-04-19 2024-04-19
Actual end date 2024-04-23
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments